2022-11-01 2023-10-31 false Capium Accounts Production 1.1 12582981 bus:AbridgedAccounts 2022-11-01 2023-10-31 12582981 bus:FRS102 2022-11-01 2023-10-31 12582981 bus:AuditExemptWithAccountantsReport 2022-11-01 2023-10-31 12582981 bus:SmallCompaniesRegimeForAccounts 2022-11-01 2023-10-31 12582981 bus:PrivateLimitedCompanyLtd 2022-11-01 2023-10-31 12582981 2022-11-01 2023-10-31 12582981 2023-10-31 12582981 bus:RegisteredOffice 2022-11-01 2023-10-31 12582981 core:WithinOneYear 2023-10-31 12582981 core:AfterOneYear 2023-10-31 12582981 bus:Director1 2022-11-01 2023-10-31 12582981 bus:Director1 2023-10-31 12582981 bus:Director1 2021-11-01 2022-10-31 12582981 2021-11-01 12582981 bus:LeadAgentIfApplicable 2022-11-01 2023-10-31 12582981 2021-11-01 2022-10-31 12582981 2022-10-31 12582981 core:WithinOneYear 2022-10-31 12582981 core:AfterOneYear 2022-10-31 12582981 bus:EntityAccountantsOrAuditors 2021-11-01 2022-10-31 12582981 bus:OrdinaryShareClass1 2022-11-01 2023-10-31 12582981 bus:OrdinaryShareClass1 2023-10-31 12582981 bus:OrdinaryShareClass1 2021-11-01 2022-10-31 12582981 bus:OrdinaryShareClass1 2022-10-31 12582981 core:FurnitureFittings 2022-11-01 2023-10-31 12582981 core:FurnitureFittings 2023-10-31 12582981 core:FurnitureFittings 2022-10-31 12582981 core:ComputerEquipment 2022-11-01 2023-10-31 12582981 core:ComputerEquipment 2023-10-31 12582981 core:ComputerEquipment 2022-10-31 12582981 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-10-31 12582981 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2022-10-31 12582981 core:CostValuation core:Non-currentFinancialInstruments 2023-10-31 12582981 core:CostValuation core:Non-currentFinancialInstruments 2022-10-31 12582981 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2023-10-31 12582981 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2023-10-31 12582981 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2023-10-31 12582981 core:Non-currentFinancialInstruments 2023-10-31 12582981 core:Non-currentFinancialInstruments 2022-10-31 12582981 core:ShareCapital 2023-10-31 12582981 core:ShareCapital 2022-10-31 12582981 core:RetainedEarningsAccumulatedLosses 2023-10-31 12582981 core:RetainedEarningsAccumulatedLosses 2022-10-31 12582981 dpl:Item1 2022-11-01 12582981 dpl:Item1 2023-10-31 12582981 dpl:Item1 2021-11-01 12582981 dpl:Item1 2022-10-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 12582981
England

 

 

 

YBS MEDICAL LTD


Abridged Accounts
 


Period of accounts

Start date: 01 November 2022

End date: 31 October 2023
Accountants report
You consider that the company is exempt from an audit for the year ended 31 October 2023 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year.
In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us.
We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts.
SS ACCOUNTANTS LTD
31 October 2023



....................................................
SS ACCOUNTANTS LTD
2 EGAR WAY
BRETTON
Peterborough
PE3 9AE
30 July 2024
1
 
 
Notes
 
2023
£
  2022
£
Fixed assets      
Tangible fixed assets 3 1,174    2,913 
1,174    2,913 
Current assets      
Debtors 6,457    6,893 
Cash at bank and in hand 27,995    12,458 
34,452    19,351 
Creditors: amount falling due within one year (5,525)   (5,880)
Net current assets 28,927    13,471 
 
Total assets less current liabilities 30,101    16,384 
Net assets 30,101    16,384 
 

Capital and reserves
     
Called up share capital 4 50    50 
Profit and loss account 30,051    16,334 
Shareholders' funds 30,101    16,384 
 


For the year ended 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 30 July 2024 and were signed by:


-------------------------------
Dr Saeeda Parveen
Director
2
General Information
YBS MEDICAL LTD is a private company, limited by shares, registered in England, registration number 12582981, registration address 2 EGAR WAY, BRETTON , PETERBOROUGH, CAMBRIDGESHIRE, PE3 9AE.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared on the going concern basis and under the historical cost convention in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Going concern basis
The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.
Turnover
Turnover comprises the invoiced value of services supplied by the company, net of trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Computer Equipment 3 Straight Line
Fixtures and Fittings 5 Straight Line
2.

Average number of employees


Average number of employees during the year was 2 (2022 : 2).
3.

Tangible fixed assets

Cost or valuation Fixtures and Fittings   Computer Equipment   Total
  £   £   £
At 01 November 2022 2,935    3,458    6,393 
Additions    
Disposals    
At 31 October 2023 2,935    3,458    6,393 
Depreciation
At 01 November 2022 1,174    2,306    3,480 
Charge for year 587    1,152    1,739 
On disposals    
At 31 October 2023 1,761    3,458    5,219 
Net book values
Closing balance as at 31 October 2023 1,174      1,174 
Opening balance as at 01 November 2022 1,761    1,152    2,913 


4.

Share Capital

Allotted, called up and fully paid
2023
£
  2022
£
100 Class A shares of £0.50 each 50    50 
50    50 

3